Phillip A. Sharp - 01 Jun 2022 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Reporting relationship: Director
Issuer ticker: SYRS
Reported as of: 01 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2022, 19:08:34 UTC
Prior SEC filing: 25 May 2022
Next SEC filing: 17 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Todd Rosenthal, as attorney-in-fact

Key filing fact

Phillip A. Sharp filed Form 4 for Syros Pharmaceuticals, Inc. (SYRS) on 02 Jun 2022.

Key facts

This page summarizes Phillip A. Sharp's Form 4 filing for Syros Pharmaceuticals, Inc. (SYRS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jun 2022, 19:08.

Change

Previous filing in this sequence was filed on 25 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SYRS transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +17,500
Change %
Price: $0.000000
Shares after: 17,500
Date: 01 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,500
Exercise price: $0.7800
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.

SEC remarks

Exhibit 24: Power of Attorney